References
- Ahmadiyazdi C, Narmani MR, Sadri B (2004) Cutaneous leishmaniasis in Iran. Int J Infect Dis 12: 1-9 https://doi.org/10.1016/S1201-9712(07)00222-6
- Ajdary S, Alimphammadian MH, Kharazimi A (2000) Comparsion of immune profile of non healing cutaneous leishmaniasis patients with those with active lesions and those who have recovered from infection. Infect Immun 68: 1760-64 https://doi.org/10.1128/IAI.68.4.1760-1764.2000
- Alimohammadian MH, Almasi H, Khabiri AR, Hatam G, Amirkhani A (1999) Identification of species and characteristics of an outbreak of cutaneous leishmaniasis in a new focus of Iran. Iranian Biomed J 3: 31-39
- Berman JD (1997) Human leishmaniasis: Clinical, diagnostic and chemotherapeutic developments in the last 10 years. Clin Infect Dis 24: 684-703 https://doi.org/10.1093/clind/24.4.684
- Edrissian GH, Zoevein Z, Nadim A (1982) A simple tecchnique for preparation of smears from the ear of Rhombomys opimus for the detection of leishmanial infection. Trans R Soc Trop Med Hyg 76: 706-707
- Hanafi AA, Dehghani A, Jafari R, Ehrampoosh MH (2002) Efficacy of control program of zoonotic cutaneous leishmaniasis in a new focus of the disease. Med J Mashhad University of Medical Sciences 46: 80-87
- Herwaldt BL (1999) Leishmaniasis. Lancet 354: 1339-64
- Javadian E, Nadim A, Tahvildari A, Assefi V (1967) Epidemiology of cutaneous leishmaniasis in Korassan Iran. Bull Soc Path Exot 69: 140-143
- Kafetzis DA (2003) An overview of pediatric leishmaniasis. J Postgrad Med 49: 31-8 https://doi.org/10.4103/0022-3859.930
- Kharfi M, Benmously R, Fekih N, Daoud M, Kamoun MR (2004) Childhood leishmaniasis : Report of 106 cases. Dermatol Online J 10: 1-7
- Khoury S, Saliba EK, Oumeish OY, Tawfig MR (1996) Epidemiology of cutaneous leishmaniasis in Jordan. Int J Dermatol 35: 566-559 https://doi.org/10.1111/j.1365-4362.1996.tb03656.x
- Markele WH, Khaldoun MMO (2004) Cutaneous leishmaniasis: recognition and treatment. American Family Physician, pp.1-9
- Moaddeb A, Gettner S, and Ardehali S (1993) Studies on the causative agent of cutaneous leishmaniasis in Shiraz Iran. Iran J Med Sci 18: 28-33
- Momeni A (1994) Clinical picture of cutaneous leishmaniasis in Isfahan, Iran. Int J Dermatol 33: 260-5 https://doi.org/10.1111/j.1365-4362.1994.tb01039.x
- Nadim A, Faghih MA (1968) The epidemiology of cutaneous leishmaniasis in Isfahan province of Iran. Trans R Soc Trop Med Hyg 62: 534-542 https://doi.org/10.1016/0035-9203(68)90140-5
- Nadim A, Seyedi RMA (1971) A brief review of the epidemiology of various types of leishmaniasis in Iran. Acta Med Iran 8: 99-106
- Ozbel Y, Turgay N, Ozensoy S, Ozbilgin A, Alkan MZ (1995) Epidemiology, diagnosis and control of leishmaniasis in the Mediterranean region. Ann Trop Med Parasitol 89: 89-93
- Sadr F, Talari SA (1998) Effect of glucantime on electrocardiogram of patients suffering from cutaneous leishmaniasis. Feyz, Kashan University of Medical Sciences 5: 13-20
- Salimi M (2000) A clinical and epidemiological comparison on the cutaneous leishmaniasis in the city and villages of Isfahan. Iran J Public Health 2: 214-219
- Selim MM, Vlasin Z, Jaroskova L (1990) Leishmaniasis, currently recommended treatment. Int J Dermatol 29: 318-21 https://doi.org/10.1111/j.1365-4362.1990.tb04750.x
- Talari SA, Sadr F (2005) Treatment of cutaneous leishmaniasis: effectiveness, and adverse effects of the drugs. Feyz, Kashan University of Medical Sciences 33: 85-94
- Talari SA, Vakili Z, Emami AH (1999) Effect of glucantime on blood parameters in patients with cutaneous leishmaniasis. Feyz, Kashan University of Medical Sciences 10: 17-22
- World Health Organization (1984) Expert committee: the leishmaniasis. WHO Tech Rep Ser No. 701: 2-4
- World Health Organization (1990) Expert committee: epidemiological aspects. In: Control of the leishmaniasis. WHO Tech Rep Ser No. 793: 41-46
- Yaghoobi MR, Akhavan AA, Zahrai AR (2003) Epidemiological study in a new focus of cutaneous leishmaniasis in the Islamic Republic of Iran. East Mediter Health J 9: 65-72
- Yaghoobi MR, Hanafi AA, Akhavan AA, Zahrai AR, Mohebali M (2001) Epidemiological study in a new focus of cutaneous leishmaniasis due to Leishmania major in Ardestantown, central Iran. Acta Trop 79: 115-121 https://doi.org/10.1016/S0001-706X(01)00085-7
- Yaghoobi MR, Hanafi AA, Javadian E, Mohebali M (2002) A new focus of cutaneous leishmaniasis caused by Leishmania tropica. Saudi Med J 23: 291-294
- Yaghoobi MR, Jafari R, Hanafi AA (2004) A new epidemic focus of zoonotic cutaneous leishmaniasis in central Iran. Ann Saudi Med 24: 98-101 https://doi.org/10.5144/0256-4947.2004.98